Unconfigured Ad

Collapse
X
 
  • Time
  • Show
Clear All
new posts
  • shazzle
    Junior Member
    • Mar 2010
    • 3

    #1

    RNAi questions from a bioinformatician

    Hi guys,

    I have a few questions. Pardon me if I sound as if I'm just starting out in RNAi studies (which I am ).

    1. Is there a consensus that miRNA will only bind to the 3' UTR region only for interference, and does siRNA and shRNA exhibit the same action of binding to 3' UTR for interference?

    2. If 1. is true, can miRNA and si/shRNA bind to other regions besides the 3' UTR and also degrades/inhibits the mRNA?

    3. For off-target effects, can the un-intended target become degraded as a result of the off-target binding?

    Thanks!
  • krobison
    Senior Member
    • Nov 2007
    • 734

    #2
    You really should find a good, recent & in depth review of the subject (try Reviews in... or Nature Reviews) for your first 2; I've been out of the field too long to answer those. It may also not be a question of absolutes but efficiency; certain locations in the mRNA may be more efficient than others.

    Your #3 is the major mode of off-target effects nowadays (if experiments are performed correctly).

    More generic off-target effects can come from either (a) overloading the processing machinery or (b) triggering an anti-viral response. Both are controlled by minimizing the dose of siRNA.

    Comment

    Latest Articles

    Collapse

    • SEQadmin2
      Multiomic Liquid Biopsy: What DNA/RNA Panels Reveal That DNA Alone Can’t
      by SEQadmin2



      Tumors contain complex mixtures of cell populations that evolve in response to treatment and host-specific factors. Tissue biopsies provide only static snapshots of a tumor’s state. But what if we could follow that evolution over time using a minimally invasive technique?

      Liquid biopsies can detect tumor-derived material circulating in the bloodstream, providing a way to study treatment response, detect emerging resistance, and discover new biomarkers. Circulating
      ...
      10-14-2026, 09:55 AM
    • SEQadmin2
      New Genomics Technologies Take Aim at Long-Standing Limits
      by SEQadmin2


      Researchers using sequencing and genomics tools often have to make trade-offs. They can choose between speed or scale, short reads or long-range information, or targeted panels or a view of the whole transcriptome. New technologies that have been released this year are built to address those tough choices.

      We asked six companies the same four questions to learn about their latest products. The new technologies bring a lot to the table, including rethinking sequencing
      ...
      09-28-2026, 10:25 AM

    ad_right_rmr

    Collapse

    News

    Collapse

    Topics Statistics Last Post
    Started by SEQadmin2, 10-22-2026, 11:13 AM
    0 responses
    30 views
    0 reactions
    Last Post SEQadmin2  
    Started by SEQadmin2, 10-22-2026, 10:48 AM
    0 responses
    22 views
    0 reactions
    Last Post SEQadmin2  
    Started by SEQadmin2, 10-15-2026, 10:52 AM
    0 responses
    39 views
    0 reactions
    Last Post SEQadmin2  
    Started by SEQadmin2, 10-14-2026, 05:39 AM
    0 responses
    45 views
    0 reactions
    Last Post SEQadmin2  
    Working...